Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
WHO/HTM/HIV/2007.01 WHO/HTM/TB/2007.380
Training for staff working at DR-TB management centres.
Training modules
Framework for implementation.
The END TB Strategy.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
Standard Operating Procedures for Implementation of TB Activities at HIV/AIDS Service Delivery Sites
Key populations brief
Accessed November 2017
Good practice guide
Supporting community action on HIV, health and rights to end AIDS
Annex 1: Measuring progress towards targets
Annex 2: Modelling the impact of the 90-(90)-90 strategy
Annex 3: Investment packages by country setting
Annex 4: Country strategies
Annex 5: Strategic frameworks for research and development for new tools
Annex 6 : Estimating the cost of the 90-(90)-...90 strategy
Accessed November 2017
more